AME.NYSEAmetek Inc/

Form 4: AMETEK Senior VP Amodei Reports Equity Grants

Sentiment:

Insider Transaction Report


AMETEK's Senior VP, Controller Robert Amodei reported the acquisition of restricted stock and stock options, alongside a tax-related disposition of shares.

Summary

  • Robert Amodei, Senior VP, Controller of AMETEK, Inc. (AME), reported transactions on March 18, 2026.
  • Acquired 360 shares of Common Stock as restricted stock under the 2020 Omnibus Incentive Compensation Plan at a price of $212.77 per share.
  • Disposed of 69 shares of Common Stock at $212.77 per share to cover tax obligations.
  • Acquired 1,130 stock options with an exercise price of $212.77, exercisable in three equal annual installments starting March 18, 2027, and expiring on March 18, 2036.
  • Following these transactions, Amodei directly owns 44,221 shares of Common Stock and 1,130 stock options, and indirectly owns 3,149 shares via a 401k Plan and 711 shares via Common Stock/Serp.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine insider transaction reporting executive compensation in the form of equity grants, which generally aligns management incentives with shareholder interests. The tax-related disposition is a standard practice.

Positives

  • The acquisition of restricted stock and stock options indicates continued alignment of management's interests with shareholders.
  • The grants are part of the company's 2020 Omnibus Incentive Compensation Plan, suggesting a structured approach to executive compensation.

Negatives

  • The disposition of 69 shares was solely for tax withholding purposes, which is a standard practice and not inherently negative.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance, as it primarily reports insider transactions.

Industry Context

StockSavvy.ai notes that insider transactions, such as those reported in a Form 4, provide transparency into executive compensation and ownership changes. While not directly indicative of operational performance, the grant of equity awards like restricted stock and stock options is a common practice across industries to incentivize long-term performance and align management interests with shareholder value, particularly in industrial technology sectors where AMETEK operates.

Comparison to Industry Standards

  • NA

Stakeholder Impact

  • Shareholders: The equity grants align the interests of a key executive with shareholders, potentially incentivizing long-term value creation.
  • Employees: The grants are part of an incentive compensation plan, which can be a positive signal for employee retention and motivation within the executive ranks.

Next Steps

  • The stock options will become exercisable in three equal annual installments beginning on March 18, 2027.

Key Dates

DateDescription
03/18/2026Transaction date for acquisition of restricted stock and stock options, and disposition of shares for tax withholding.
03/18/2027First date stock options become exercisable (first of three equal annual installments).
03/18/2036Expiration date for the acquired stock options.
03/19/2026Date the Form 4 was signed by Lynn Carino, attorney-in-fact for Mr. Amodei.

Recommendation

hold

This Form 4 filing details routine executive compensation in the form of restricted stock and stock options, along with a standard tax-related share disposition. It does not provide new information that would fundamentally alter the investment thesis for AMETEK. The transactions reflect standard corporate governance practices for aligning executive incentives with shareholder value, thus a 'hold' recommendation is appropriate as there's no new catalyst for a 'buy' or 'sell' decision based solely on this filing.

Keywords

AMETEK, AME, Form 4, Insider Trading, Stock Options, Restricted Stock, Executive Compensation, Robert Amodei, Senior VP Controller

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.